BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

703 related articles for article (PubMed ID: 28969607)

  • 1. A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa.
    Huerga H; Shiferie F; Grebe E; Giuliani R; Farhat JB; Van-Cutsem G; Cohen K
    BMC Infect Dis; 2017 Sep; 17(1):653. PubMed ID: 28969607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short Communication: Assessing Estimates of HIV Incidence with a Recent Infection Testing Algorithm That Includes Viral Load Testing and Exposure to Antiretroviral Therapy.
    Kim AA; Rehle T
    AIDS Res Hum Retroviruses; 2018 Oct; 34(10):863-866. PubMed ID: 29926735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of viral load to improve survey estimates of known HIV-positive status and antiretroviral treatment coverage.
    Young PW; Zielinski-Gutierrez E; Wamicwe J; Mukui I; Kim AA; Waruru A; Zeh C; Kretzschmar ME; De Cock KM
    AIDS; 2020 Mar; 34(4):631-636. PubMed ID: 31794520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress towards the UNAIDS 90-90-90 goals by age and gender in a rural area of KwaZulu-Natal, South Africa: a household-based community cross-sectional survey.
    Huerga H; Van Cutsem G; Ben Farhat J; Puren A; Bouhenia M; Wiesner L; Dlamini L; Maman D; Ellman T; Etard JF
    BMC Public Health; 2018 Mar; 18(1):303. PubMed ID: 29499668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates and Predictors of Non-Adherence to Antiretroviral Therapy among HIV-Positive Individuals in Kenya: Results from the Second Kenya AIDS Indicator Survey, 2012.
    Mukui IN; Ng'ang'a L; Williamson J; Wamicwe JN; Vakil S; Katana A; Kim AA
    PLoS One; 2016; 11(12):e0167465. PubMed ID: 27907114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV care coverage among HIV-positive adolescent girls and young women in South Africa: Results from the HERStory Study.
    Mathews C; Cheyip M; Beauclair R; Puren A; Lombard C; Jonas K; Ayalew KA; Govindasamy D; Kuo C; Dietrich J; Abdullah F; Gray G
    S Afr Med J; 2021 Apr; 111(5):460-468. PubMed ID: 34852889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress towards the UNAIDS 95-95-95 targets among pregnant women in South Africa: Results from the 2017 and 2019 national Antenatal HIV Sentinel Surveys.
    Woldesenbet S; Cheyip M; Lombard C; Manda S; Ayalew K; Kufa T; Puren A
    PLoS One; 2022; 17(7):e0271564. PubMed ID: 35862306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral suppression among pregnant adolescents and women living with HIV in rural KwaZulu-Natal, South Africa: a cross sectional study to assess progress towards UNAIDS indicators and Implications for HIV Epidemic Control.
    Ntombela NP; Kharsany ABM; Soogun A; Yende-Zuma N; Baxter C; Kohler HP; McKinnon LR
    Reprod Health; 2022 May; 19(1):116. PubMed ID: 35550580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-level HIV incidence estimates using a combination of synthetic cohort and recency biomarker approaches in KwaZulu-Natal, South Africa.
    Grebe E; Welte A; Johnson LF; van Cutsem G; Puren A; Ellman T; Etard JF; ; Huerga H
    PLoS One; 2018; 13(9):e0203638. PubMed ID: 30212513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-sectional estimates revealed high HIV incidence in Botswana rural communities in the era of successful ART scale-up in 2013-2015.
    Moyo S; Gaseitsiwe S; Mohammed T; Pretorius Holme M; Wang R; Kotokwe KP; Boleo C; Mupfumi L; Yankinda EK; Chakalisa U; van Widenfelt E; Gaolathe T; Mmalane MO; Dryden-Peterson S; Mine M; Lebelonyane R; Bennett K; Leidner J; Wirth KE; Tchetgen Tchetgen E; Powis K; Moore J; Clarke WA; Lockman S; Makhema JM; Essex M; Novitsky V
    PLoS One; 2018; 13(10):e0204840. PubMed ID: 30356287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative surveys.
    Haas AD; Radin E; Hakim AJ; Jahn A; Philip NM; Jonnalagadda S; Saito S; Low A; Patel H; Schwitters AM; Rogers JH; Frederix K; Kim E; Bello G; Williams DB; Parekh B; Sachathep K; Barradas DT; Kalua T; Birhanu S; Musuka G; Mugurungi O; Tippett Barr BA; Sleeman K; Mulenga LB; Thin K; Ao TT; Brown K; Voetsch AC; Justman JE
    J Int AIDS Soc; 2020 Nov; 23(11):e25631. PubMed ID: 33225559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in HIV viral suppression in KwaZulu-Natal, South Africa: Community-based cross sectional surveys 2018 and 2013. What remains to be done?
    Conan N; Simons E; Chihana ML; Ohler L; FordKamara E; Mbatha M; vanCutsem G; Huerga H
    PLoS One; 2022; 17(3):e0265488. PubMed ID: 35324923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HIV care cascade for adolescents initiated on antiretroviral therapy in a health district of South Africa: a retrospective cohort study.
    Haghighat R; Toska E; Bungane N; Cluver L
    BMC Infect Dis; 2021 Jan; 21(1):60. PubMed ID: 33435861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Closer to 90-90-90. The cascade of care after 10 years of ART scale-up in rural Malawi: a population study.
    Maman D; Chilima B; Masiku C; Ayouba A; Masson S; Szumilin E; Peeters M; Ford N; Heinzelmann A; Riche B; Etard JF
    J Int AIDS Soc; 2016; 19(1):20673. PubMed ID: 26894388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study.
    Solomon SS; Mehta SH; McFall AM; Srikrishnan AK; Saravanan S; Laeyendecker O; Balakrishnan P; Celentano DD; Solomon S; Lucas GM
    Lancet HIV; 2016 Apr; 3(4):e183-90. PubMed ID: 27036994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ART Denial: Results of a Home-Based Study to Validate Self-reported Antiretroviral Use in Rural South Africa.
    Manne-Goehler J; Rohr J; Montana L; Siedner M; Harling G; Gómez-Olivé FX; Geldsetzer P; Wagner R; Wiesner L; Kahn K; Tollman S; Bärnighausen TW
    AIDS Behav; 2019 Aug; 23(8):2072-2078. PubMed ID: 30523490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Home testing and counselling to reduce HIV incidence in a generalised epidemic setting: a mathematical modelling analysis.
    Ying R; Sharma M; Celum C; Baeten JM; van Rooyen H; Hughes JP; Garnett G; Barnabas RV
    Lancet HIV; 2016 Jun; 3(6):e275-82. PubMed ID: 27240790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa.
    Onoya D; Nattey C; Budgell E; van den Berg L; Maskew M; Evans D; Hirasen K; Long LC; Fox MP
    AIDS Patient Care STDS; 2017 May; 31(5):205-212. PubMed ID: 28445088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.